Souzhou Ribo Life Science
Souzhou Ribo Life Science develops nucleic acid drugs and related products based on the RNA interference technology. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€300m (Public information from Jul 2022)
Wuhan Hubei (HQ)
Authorizing premium user...